Treating Metabolic Disorders Through Novel Pathways

We are a clinical-stage biotech company pioneering first-in-class treatments to revolutionize metabolic health. Our mission is to redefine the management of diabetes, obesity, and other metabolic diseases, which impact millions globally. By harnessing our groundbreaking technology, we aim to transform therapeutic options across a spectrum of metabolic disorders, through the development of small molecules with distinct and novel signaling profiles.